Newer Oral Anticoagulants Beneficial for Atrial Fibrillation


In patients with atrial fibrillation (AF), novel oral anticoagulants (NOACs) appear to provide greater overall clinical benefit when compared with vitamin K antagonists. A systematic review and meta-analysis found than NOACs were associated with lower rates of total mortality, cardiovascular mortality, stroke, and systemic embolism in patients with AF when compared with vitamin K antagonists.

Abstract: Circulation, November 13, 2012.

Submit a Comment

Your email address will not be published. Required fields are marked *

20 − 19 =